rs2866413
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005908.4(MANBA):c.2102C>T(p.Thr701Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.523 in 1,608,224 control chromosomes in the GnomAD database, including 223,306 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_005908.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MANBA | NM_005908.4 | c.2102C>T | p.Thr701Met | missense_variant | 15/17 | ENST00000647097.2 | NP_005899.3 | |
MANBA | XM_047415692.1 | c.2027C>T | p.Thr676Met | missense_variant | 16/18 | XP_047271648.1 | ||
MANBA | XM_047415693.1 | c.2027C>T | p.Thr676Met | missense_variant | 16/18 | XP_047271649.1 | ||
MANBA | XM_047415694.1 | c.1454C>T | p.Thr485Met | missense_variant | 11/13 | XP_047271650.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MANBA | ENST00000647097.2 | c.2102C>T | p.Thr701Met | missense_variant | 15/17 | NM_005908.4 | ENSP00000495247.1 |
Frequencies
GnomAD3 genomes AF: 0.549 AC: 83451AN: 151906Hom.: 23342 Cov.: 33
GnomAD3 exomes AF: 0.541 AC: 135812AN: 251266Hom.: 37895 AF XY: 0.529 AC XY: 71840AN XY: 135812
GnomAD4 exome AF: 0.521 AC: 758213AN: 1456200Hom.: 199930 Cov.: 35 AF XY: 0.517 AC XY: 375007AN XY: 724730
GnomAD4 genome AF: 0.549 AC: 83529AN: 152024Hom.: 23376 Cov.: 33 AF XY: 0.548 AC XY: 40747AN XY: 74294
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 21, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 16, 2013 | - - |
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 13, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Oct 23, 2015 | - - |
Beta-D-mannosidosis Benign:3
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at